# GenePeeks

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genepeeks

- Industry: Biotechnology
- Headquarters: New York, US
- Website: www.genepeeks.com
- Total disclosed funding: $10M
- Latest round: Series B (Sep 8, 2016)
- Investors on record: 4

## About

GenePeeks, Inc. is a biotechnology company specializing in genetic risk assessment and analysis to improve reproductive health and outcomes. Their innovative approach utilizes cutting-edge technology to predict genetic compatibility between prospective parents.Founded in 2009 and headquartered in New York, US, GenePeeks, Inc. focuses on genetic risk analysis to enhance reproductive health. The company has secured funding through several rounds, with the most recent being a Series B funding round in September 2016, raising USD 10.000 mn led by 5AM Ventures. The company has successfully completed four funding deals, with a current valuation of USD 35.95 mn. Lee Silver, the founder, has a history in biotechnology and has contributed to the company's development through its strategic pivots.GenePeeks, Inc. offers advanced genetic testing services that assess the genetic compatibility of prospective parents. Their core service involves a proprietary algorithm that analyzes genetic data to identify potential risks of inherited diseases. This service is aimed at individuals and couples planning to conceive, providing them with critical insights into their genetic backgrounds to facilitate informed reproductive choices.The revenue model of GenePeeks, Inc. is based on subscription services for its genetic testing solutions. Clients typically engage in various subscription plans, which provide access to genetic analysis tailored to their specific needs. This structure ensures a predictable revenue stream as clients renew their services periodically, with the company's flagship offerings being integral to its overall revenue generation.GenePeeks, Inc. plans to leverage its recent Series B funding of USD 10.000 mn to expand its product offerings and enhance its technological capabilities. The company is in the process of designing new genetic analysis products aimed at both consumer and clinical markets, with anticipated launches in the next 12 months. Additionally, GenePeeks is targeting expansion into international markets including Europe and Asia by 2025, to broaden its reach and impact in reproductive health.

## Funding rounds

- Series B, Sep 8, 2016, $10M — Alta Partners, Alexandria Venture Investments, 5AM Ventures, Columbus Nova Technology Partners

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series B
- Columbus Nova Technology Partners (https://capitalatlas.ai/funds/columbus-nova-technology-partners) — Series B